Bea Arnold

🔬Cancer research: a CHF 1,4 million grant from Fondation Leenaards🇨🇭. Three Swiss researchers from EPFL, Université de Genève and HUG - Hôpitaux Universitaires de Genève are pioneering a groundbreaking strategy to overcome #immunotherapy resistance by targeting #cancer cells' physical properties rather than their biology. The goal: make their membranes stiffer, hence making it possible for T-cells to bind to tumors and destroy them. Congratulations to Prof. Camilla Jandus, Prof. Li Tang and Prof. Olivier Michielin for this promosing approach that could revolutionize cancer treatment. 📸 © Fondation Leenaards / Alban Kakulya. 🔗 https://lnkd.in/eRW4SiaF

150

4 Kommentare

🚀 Exciting Research Milestone at Universitätsklinik Balgrist! We are proud to announce that two Swiss National Science Foundation (SNSF) projects and one BRIDGE programme proposal have been approved — driving forward innovation and translational science at the intersection of medicine, engineering, and data science. 🔹 SNSF Project "Data-Driven Surgical Training with Multi-Modal Digital Twins", Prof. Philipp Fürnstahl, Prof. Mazda Farshad, Prof. Siyu Tang🔹 State-of-the-art VR surgical training tools have great potential for personalized, skill-based learning. This project takes a data-driven approach to surgical education, building digital twins that extend current VR surgical training frameworks with realistic tool-tissue interaction, human behavior, and acoustic signals to recreate complex interventional environments. The framework aims to bridge the gap between simulation and real-world patient treatment to improve the training experience for the surgeons of tomorrow. 🔹 SNSF Project "Under the Skin: Unraveling the Neuromodulatory Role of Skin Cells in Complex Regional Pain Syndrome", Prof. Stefan Dudli, Prof. Florian Brunner, Prof. Michèle Hubli, Prof. Sibylle Grad🔹 This interdisciplinary project investigates the role of skin cells in modulating pain in Complex Regional Pain Syndrome (CRPS). By creating the first single-cell atlas of CRPS-affected skin, the team aims to uncover biological subgroups, identify novel cell-based biomarkers, and lay the foundation for precision medicine in chronic pain. The findings could redefine CRPS as a neuro-immuno-cutaneous condition and open new therapeutic avenues for pain and inflammation disorders. 🔹 BRIDGE Project "Robotic and Minimally Invasive Laser Tissue Soldering", Dr. Oscar Cipolato, Prof. Inge Herrmann🔹 This project pioneers iSoldering, an intelligent tissue closure platform for robotic and minimally invasive surgery. Combining laser-activated bonding with real-time temperature feedback, it offers a safer, more precise, and efficient alternative to conventional sutures and adhesives, enhancing healing and surgical precision while reducing complications. These projects reflect our commitment to advancing science and innovation across orthopaedics, surgery, and translational medicine. 👉 Supported by the Swiss National Science Foundation (SNSF) and the BRIDGE Funding Programme. 👉 Research conducted at Universitätsklinik Balgrist, in collaboration with University Hospital Zürich (UZH), ETH Zürich, AO Research Institute Davos (ARI), Rheumatology USZ, and OR-X (Operating Room X) at Balgrist Campus AG and collaborating Institutions. #Research #Innovation #Surgery #DigitalTwins #CRPS #LaserSurgery #TranslationalMedicine #Balgrist #Universitätsklinik #UZH #ETH #ORX #ARIDavos #USZ

163

3 Kommentare

💡 𝗕𝗮𝘀𝗲𝗹 𝗔𝗿𝗲𝗮: 𝗔 𝗛𝘂𝗯 𝗳𝗼𝗿 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝗮𝗻𝗱 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 With a strong legacy in biotech, pharmaceuticals, medtech, and Industry 4.0, the Basel Area is a hotspot for innovators and entrepreneurs. At the core of this ecosystem lies Switzerland’s largest life science-focused innovation district, bringing startups, research institutes, and global companies together. This is also where Switzerland Innovation Park Basel Area is positioned. Collaboration drives progress here: sharing knowledge, resources, and expertise creates an environment where ideas turn into breakthroughs. 🚀 Located at the tri-national border of France and Germany, the Basel Area offers unique access to talent and markets, helping companies scale across Europe. 🏙️ High quality of life adds to its appeal, Basel ranks among the top European cities to live and work! 👉 Explore the ecosystem: https://lnkd.in/e_Btc64W #SwitzerlandInnovation #WhySwitzerland #WhyBaselArea #LifeScience #Ecosystem University of Basel Basel Area Business & Innovation Roche Department of Biomedicine Friedrich Miescher Institute for Biomedical Research University Hospital Basel Tech Park Basel Novartis ETH-Department of Biosystems Science and Engineering (D-BSSE) Biozentrum, University of Basel University of Applied Sciences and Arts Northwestern Switzerland FHNW

146

5 Kommentare

Austria’s innovative life sciences scene: watch out for these companies, start-ups, and spin-offs 🧬 Austria has earned an outstanding reputation as a research and production location in the #lifesciences – thanks to the synergy between top research institutions, excellent medical practice, an effective education system and a vibrant mix of #startups and global companies. 🔗 Read about how the country wants to perfect the transfer of knowledge from #science to commercial application in #industry & more here: https://lnkd.in/eZr9wy8A #LifeScience #Investing #VCMagazin Karin Hofelich #ImpactLifeSciences Austria Wirtschaftsservice (aws) ABA – INVEST in AUSTRIA #startup #Austria #Vienna #AI #Bio #LS #VC #PE

39

2 Kommentare